Local immunotherapy: Pharmacokinetics and efficacy

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 53, Issue 5, 1998, Pages 477-484

  Passalacqua, G ^a   Bagnasco, M ^a   Mariani, G ^a   Falagiani, P ^b   Canonica, G W ^a,c  

^a UNIVERSITY OF GENOA   (Italy)

^b Lofarma SpA   (Italy)

^c Allergy and Respiratory Diseases   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E;

ALLERGIC RHINITIS; ALLERGY; CAT; CLINICAL TRIAL; CONFERENCE PAPER; DESENSITIZATION; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG FORMULATION; ENCAPSULATION; ENTERIC COATED TABLET; GRASS; HEADACHE; HUMAN; IMMUNOGENICITY; IMMUNOMODULATION; INTRANASAL DRUG ADMINISTRATION; MITE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PRURITUS; RAGWEED;

EID: 0031809668     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1998.tb04084.x     Document Type: Conference Paper

References (70)

1. Noon L. Prophylactic inoculation against hayfever. Lancet 1911;1:1572.
2. Committee on the Safety of Medicines. CSM update. Desensitizing vaccines. BMJ 1986;293:948.
3. Lockey RF, Benedict LM, Turkeltaub PC, Bukantz SC. Fatalities from immunotherapy and skin testing. J Allergy Clin Immunol 1987;79:660-77.
4. Johnstone D. A study of the natural history of bronchial asthma in children. Am J Dis Child 1968;115:213-21.
5. Johnstone D, Dutton A. The value of hyposensitization therapy for bronchial asthma in children: a 14 year study. Pediatrics 1968;42:793-9.
6. Rachemann FN, Edwards MC. Asthma in children. A follow up study on 688 patients after an interval of 20 years. N Engl J Med 1952;246:915-19.
7. Abramson MJ, Puy RM, Weiner JM. Is allergen immunotherapy effective in asthma? A meta-analysis of randomized controlled trials. Am J Respir Crit Care Med 1995;151: 969-74.
8. Passalacqua G, Canonica GW. Alternative routes for allergen specific immunotherapy. J Investig Allergol Clin Immunol 1996;6:81-7.
9. Malling H-J, Weeke B, editors. Immunotherapy. EAACI position paper. Allergy 1993;48 Suppl 14:9-30.
10. Black JH. The oral administration of pollen. J Lab Clin Med 1927;12:1156.
11. Dunbar WP. The present state of knowledge of hayfever. J Hyg 1913;13:105.
12. Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994; 265:1237-40.
13. Mowart AM. The regulation of immune response to dietary proteins. Immunol Today 1987;8:93-6.
14. Holt PG, Vines J, Britten D. Sublingual allergen administration. I. Selective suppression of IgE production in rats with high allergen doses. Clin Allergy 1988;18:229-34.
15. Miller A, Lider O, Roberts AB, Sporn MB. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune response by the release of TGFbeta following antigen specific triggering. Proc Natl Acad Sci U S A 1992;89:421-5.
16. van Wilsem EJ, van Hoogsraten IM, Breve J, Scheper RJ, Kraal G. Dendritic cells of the oral mucosa and the induction of oral tolerance. A local affair. Immunology 1994;93:128-32.
17. Holt PG, Sedgwick JD. Suppression of IgE response following antigen inhalation: a natural homeostatic mechanism which limits sensitizations to aeroallergens. Immunol Today 1987;8:14-15.
18. Holt PG, McMenamin C. Defense against allergic sensitization in healthy lung: the role of inhalation tolerance. Clin Exp Allergy 1989;19:55-62.
19. Holt PG, Britten D, Sedgwick JD. Suppression of IgE responses by antigen inhalation: studies on the role of genetic and environmental factors. Immunology 1987;60:97-102.
20. Holt PG, Batty JE, Turner KJ. Inhibition of specific IgE responses in mice by pre-exposure to inhaled antigen. Immunology 1981;42:409-17.
21. Holt PG, Reid M, Britten D, Sedgwick J, Bazin H. Suppression of IgE responses by passive antigen inhalation: dissociation of local and systemic immunity. Cell Immunol 1987;104:434-9.
22. Salvaggio JE, Cavanaugh JJA, Leskowitz A. Comparison of the immunological response of normal and atopic individuals to intranasally administered antigen. J Allergy 1964;35:62-9.
23. Salvaggio JE, Castro Murillo E, Kundur. Immunological response of atopic and normal individuals to keyhole limpet hemocyanin. J Allergy 1969;44:344-54.
24. Möller C, Dreborg S, Lanner A, Björkstén B. Oral immunotherapy of children with rhinoconjunctivitis due to birch pollen allergy. Allergy 1986;41:271-9.
25. Taudorf E, Laursen CL, Lanner A, et al. Oral immunotherapy to birch pollen hay fever. J Allergy Clin Immunol 1987;80:153-61.
26. Giovane A, Bardare M, Passalacqua G, et al. A three year double blind placebo-controlled study with specific oral immunotherapy to Dermatophagoides: evidence of safety and efficacy in pediatric patients. Clin Exp Allergy 1994; 24:53-9.
27. Cooper PJ, Darbyshire, Nunn AJ, Warner JO. A controlled trial of oral hyposensitization in pollen asthma and rhinitis in children. Clin Allergy 1984;14:541-50.
28. Taudorf E, Laursen LC, Djurup R, et al. Oral administration of grass pollen to hay fever patients. An efficacy study in oral hyposensitization. Allergy 1985;40:321-35.
29. Mosbech H, Dreborg S, Madsenn F, et al. High dose grass pollen tablets used for hyposensitization in hay fever patients. A one year double blind placebo controlled study. Allergy 1987;42:451-5.
30. Oppenheimer J, Areson JG, Nelson HS. Safety and efficacy of oral immunotherapy with standardized cat extract. J Allergy Clin Immunol 1994;93:61-7.
31. van Deusen MA, Angelini BL, Cordoro KM, Seiler BA, Wood L, Skoner DP. Efficacy and safety of oral immunotherapy with short ragweed extract. Ann Allergy Asthma Immunol 1997;78:573-80.
32. Litwin A, Flanagan M, Entis G, et al. Oral immunotherapy with short ragweed in a novel encapsulated preparation: a double blind study. J Allergy Clin Immunol 1997;100:30-8.
33. Taudorf E, Lanner A, Laursen L, Björkstén B, Dreborg S, Weeke B. Specific IgG, IgE and IgA antibody response to oral immunotherapy in birch pollenosis. J Allergy Clin Immunol 1989;83:589-94.
34. Tari MG, Mancino M, Monti G. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double blind study. Allergol Immunopathol (Madr) 1990;18:277-84.
35. Fcliziani V, Lattuada G, Parmiani S, Dall'Aglio PP. Safety and efficacy of sublingual rush immunotherapy with grass allergen extracts. A double blind study. Allergol Immunopathol (Madr) 1995;23:173-8.
36. Sabbah A, Hassoun S, Le Sellin J, André C, Sicard H. A double-blind, placebo-controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extract. Allergy 1994;49:309-13.
37. Troise C, Voltolini S, Canessa A, Pecora S, Negrini AC. Sublingual immunotherapy in Parietaria pollen induced rhinitis: a double blind study. J Investig Allergol Clin Immunol 1995;5:25-30.
38. Hirsch T, Sahn M, Eupold W. Double blind placebo controlled study of sublingual immunotherapy with house dust mite extract in children. Pediatr Allergy Immunol 1997;8:21-7.
39. Passalacqua G, Albano M, Fregonese L, et al. Treatment of mite rhinoconjunctivitis with local allergoid immunotherapy: effects on allergic inflammation. Lancet 1998; 351:629-32.
40. Horak F, Jäger S, Berger U, Marks B, Temmel A, Toth J. Sublingual birch pollen extract for IT [Abstract]. Allergy 1995;50 Suppl 26:279.
41. Clavel R, Couturier P, Basset D, et al. Reduction of corticostcroid therapy by sublingual immunotherapy. Double blind study against placebo of a standardized grass pollen extract in rhinitis [Abstract]. Allergy 1995;50 Suppl 26:279.
42. Albano M, Passalacqua G, Fregonese L, et al. Effect of rush sublingual immunotherapy to Parietaria: a double blind study [Abstract]. Annual Meeting of EAACI, Rhodes, 1997. Allergy 1997;52 Suppl 37:162.
43. Johansson SGO, Deuschl H, Zetterström O. Use of glutaraldehyde-modified timothy grass pollen extract in nasal hyposensitization of hay fever. Int Arch Allergy Appl Immunol 1979;60:447-60.
44. Nickelsen JA, Goldstein S, Müller U, Wypych J, Reisman RE, Arbesman CE. Local intranasal immunotherapy for ragweed allergic rhinitis: clinical response. J Allergy Clin Immunol 1981;68:33-40.
45. Welsh PW, Zimmermann EM, Yunginger JW, Kern EB, Gleich GJ. Preseasonal intranasal immunotherapy with nebulized short ragweed extract. J Allergy Clin Immunol 1981;67:237-42.
46. Schumacher MJ, Pain MCF. Intranasal immunotherapy with polymerized grass pollen allergens. Allergy 1981;37:241-5.
47. Georgitis JW, Reisman RE, Clayton WF, Müller U, Wypych J, Arbesman CE. Local nasal immunotherapy for grass allergic rhinitis. J Allergy Clin Immunol 1983;71:71-6.
48. Georgitis JW, Clayton WF, Wypych JI, Barde SH, Rasman RE. Further evaluation of local nasal immunotherapy with aqueous and allergoid grass extract. J Allergy Clin Immunol 1984;74:694-700.
49. Andri L, Senna GE, Betteli C, Givanni S, Andri G, Falagiani P Local nasal immunotherapy for Dermatophagoides-induced rhinitis: efficacy of a powder extract. J Allergy Clin Immunol 1993;91:587-96.
50. Andri L, Senna GE, Betteli C, et al. Local nasal immunotherapy in allergic rhinitis to Parietaria. Allergy 1992;47: 318-23.
51. D'Amato G, Lobefalo G, Liccardi G, Cazzola M. A double blind placebo controlled trial of local nasal immunotherapy in allergic rhinitis to Parietaria pollen. Clin Exp Allergy 1995;25:141-8.
52. Passalacqua G, Albano M, Ruffoni S, et al. Local nasal immunotherapy to Parietaria: evidence of reduction of allergic inflammation. Am J Respir Crit Care Med 1995; 152:461-6.
53. Andri L, Senna GE, Andri G, et al. Local nasal immunotherapy for birch allergic rhinitis with extract in powder form. Clin Exp Allergy 1995;25:1092-9.
54. Andri L, Senna GE, Betteli C, et al. Local nasal immunotherapy with extract in powder form is effective and safe in grass pollen rhinitis. A double blind study on 32 patients. J Allergy Clin Immunol 1996;97:37-41.
55. Cirla AM, Sforza N, Roffi GP, et al. Preseasonal intranasal immunotherapy in birch-alder rhinitis. A double-blind study. Allergy 1996;51:299-305.
56. Bardare M, Zaini C, Novembre E, Vierucci A. Local nasal immunotherapy with a powder extract for grass pollen rhinitis in pediatric ages. A controlled study. J Investig Allergol Clin Immunol 1996;97:34-41.
57. Passalacqua G, Albano M, Pronzato C, Riccio A, Falagiani P, Canonica GW. Nasal immunotherapy to Parietaria: long-term follow-up of a double blind study. Clin Exp Allergy 1997;27:904-8.
58. Crimi E, Voltolini S, Troise C, et al. Local immunotherapy with Dermatophagoides extract in asthma. J Allergy Clin Immunol 1991;87:721-8.
59. Tari MG, Mancino M, Monti G. Immunotherapy by inhalation of allergen in powder in house dust allergic asthma. J Investig Allergy Clin Immunol 1992;2:59-67.
60. Horak F, Wheeler AW. Oral hyposensitization with enteric coated allergens as extension therapy following a basic subcutaneous course of injections. Int Arch Allergy Appl Immunol 1987;84:74-8.
61. Trede NS, Urbanek R. Combination of parenteral and oral immunotherapy in grass pollen allergic children. Allergy 1989;44:272-80.
62. Bernardis P, Agnoletto M, Puccinelli P, Parmiani S, Pozzan M. Injective vs sublingual immunotherapy in Alternaria tenuis allergic patients. J Investig Allergol Clin Immunol 1996;6:55-62.
63. Quirino T, Iemoli E, Siciliani E, Parmiani S. Sublingual vs injective immunotherapy in grass pollen allergic patients: a double blind double dummy study. Clin Exp Allergy 1996;26:1253-61.
64. Swarbrick ET, Stokes CR, Soothill JE Absorption of antigens after oral immunisation and the simultaneous induction of specific tolerance. Gut 1979;20:121-3.
65. Einarsson R, Renck B, Taudorf E. In vitro studies of degradation of birch and timothy pollen allergen preparations by human duodenal juice. Allergy 1988;43:469-75.
66. Mistrello G, Roncarolo D, Gentili M, Zanoni D, Falagiani P. Modified Par j I allergen from P. judaica pollen and its rate of absorption in rats. Immunol Lett 1993;40:31-6.
67. Mistrello G, Rapisarda G, Falagiani R Detection of IgE-binding activity in serum after intranasal treatment of normal rabbits with P. judaica extracts. Allergy 1991;46:52-5.
68. Falagiani P, Mistrello G. Pharmacokinetics of allergens after local administration. Allergy 1997;52 Suppl 33:17-21.
69. Buckle FB, Cohen AB. Nasal mucosal hyperpermeability to macromolecules in atopic rhinitis and extrinsic asthma. J Allergy Clin Immunol 1975;55:213-21.
70. Bagnasco M, Mariani G, Passalacqua G, et al. Absorption and distribution kinetics of the major Parietaria allergen administered by noninjectable routes to healthy human beings. J Allergy Clin Immunol 1997;100:122-9.